The University of Texas-San Antonio has been granted an amount of $72,000 by the National Institutes of Health via the National Institute of Allergy and Infectious Diseases to do some work on developing a vaccine that can fight Chlamydia in guinea pigs.
The leading Bacterial STD
According to the study, Chlamydia is the number one cause of bacterial STD around the world. Chlamydia infections that fail to get treated can lead to serious health problems such as infertility, ectopic pregnancy, and PID or pelvic inflammatory disease.
Immunization against Chlamydia
The vaccine aims to minimize the Chlamydia transmission. As of the moment, the researchers have come up with a vaccine that has shown potential in fighting off Chlamydia in mice, and they are pursuing more experiments and research to find out if it could work in guinea pigs, which are animals that have similar immunity and pathogenesis to Chlamydia just like human beings.
The researchers said the vaccine will hopefully able to induce immunity against the Chlamydia bacterium in guinea pigs, and if they are successful, they would be able to use it on humans in the near future.
The budget covers the research project that began on July 25, 2011, and is expected to end June 30, 2014.
If you want to prevent Chlamydia, you should always use protection when having sex and undergo Chlamydia testing on a regular basis. Doing these strategies can help you and your partner live a Chlamydia-free life.